Hoffmann-La Roche: Anemia trials

The registry lists 106 Anemia studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 66 have results posted.

Phase 1 1Phase 2 8Phase 3 48Phase 4 23No phase 27(a study in two phases counts in both)

Studies

Page 1 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.CompletedNCT03552393Phase 2Results posted
• A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With ChemotherapyCompletedNCT02767765Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing ChemotherapyCompletedNCT02761642Phase 2Results posted
• Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in CroatiaCompletedNCT02625844Results posted
• A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on DialysisCompletedNCT02567188Results posted
• Observational Study of MIRCERA in Users of Self-Application and Multidose SystemsCompletedNCT02540213Results posted
• An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney TransplantCompletedNCT02538107Results posted
• An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on HemodialysisCompletedNCT01940484Results posted
• OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on DialysisCompletedNCT01902628Results posted
• An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving ChemotherapyCompletedNCT01809314Results posted
• An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid MalignancyCompletedNCT01716559Results posted
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal AnemiaCompletedNCT01695746Results posted
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal AnemiaCompletedNCT01677767Results posted
• A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or DialysisCompletedNCT01519947Phase 4Results posted
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on HaemodialysisCompletedNCT01422824Results posted
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Anemic Patients With Chronic Kidney Disease (NORM)CompletedNCT01417377Results posted
• A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)CompletedNCT01379963Results posted
• A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL)CompletedNCT01356589Results posted
• A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal AnemiaCompletedNCT01342640Phase 4Results posted
• Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical RoutineCompletedNCT01309269Results posted
• An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)CompletedNCT01168349Results posted
• A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal AnaemiaCompletedNCT01156363Phase 4Results posted
• A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal AnaemiaTerminatedNCT01066000Phase 4Results posted
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal AnemiaCompletedNCT01051323Results posted
• A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on DialysisCompletedNCT00922116Phase 4Results posted
• A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal AnemiaCompletedNCT00882713Phase 3Results posted
• A Study of Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal AnemiaCompletedNCT00773968Phase 3Results posted
• A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)CompletedNCT00773513Phase 4Results posted
• A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy.CompletedNCT00737711Phase 4Results posted
• A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal DialysisCompletedNCT00737477Phase 3Results posted
• A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.CompletedNCT00737464Phase 4Results posted
• Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on HemodialysisCompletedNCT00717366Phase 2Results posted
• A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal AnemiaCompletedNCT00699348Phase 3Results posted
• A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal AnemiaCompletedNCT00661505Phase 3Results posted
• A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.CompletedNCT00661388Phase 3Results posted
• A Study of Intravenous Mircera in Participants With Chronic Renal Anemia Who Are on DialysisCompletedNCT00660023Phase 3Results posted
• STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis PatientsCompletedNCT00642850Phase 3Results posted
• A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal AnemiaCompletedNCT00642668Phase 4Results posted
• A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.CompletedNCT00642304Phase 3Results posted
• A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for Maintenance Treatment of Anemia in Kidney Transplant Recipients.CompletedNCT00605345Phase 3Results posted
• A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal AnemiaCompletedNCT00605293Phase 3Results posted
• A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.CompletedNCT00576628Phase 3Results posted
• A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.CompletedNCT00576303Phase 3Results posted
• A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.CompletedNCT00560404Phase 3Results posted
• A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on DialysisCompletedNCT00559637Phase 3Results posted
• A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal AnemiaCompletedNCT00550680Phase 3Results posted
• A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.CompletedNCT00546481Phase 3Results posted
• MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal AnemiaCompletedNCT00545571Phase 3Results posted
• Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal AnemiaTerminatedNCT00517881Phase 3Results posted
• LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.CompletedNCT00517413Phase 3Results posted
• A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.TerminatedNCT00462384Phase 3Results posted
• A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.TerminatedNCT00454246Phase 3Results posted
• A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.CompletedNCT00442702Phase 3Results posted
• A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.TerminatedNCT00442416Phase 3Results posted
• A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.TerminatedNCT00422513Phase 3Results posted
• A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.CompletedNCT00413894Phase 3Results posted
• A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis PatientsCompletedNCT00394953Phase 3Results posted
• A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.CompletedNCT00364832Phase 2Results posted
• (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic NephropathyCompletedNCT00354341Phase 3Results posted
• A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal AnemiaCompletedNCT00321919Phase 3Results posted
• A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal AnemiaCompletedNCT00090753Phase 3Results posted
• A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.CompletedNCT00077766Phase 3Results posted
• A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.CompletedNCT00077623Phase 3Results posted
• A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNCT00077610Phase 3Results posted
• A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.CompletedNCT00048048Phase 2Results posted
• A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal AnemiaCompletedNCT00048035Phase 2Results posted
• A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on DialysisCompletedNCT02827266Phase 3
• A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid MalignancyTerminatedNCT02624141Phase 4
• A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin BTerminatedNCT02608060Phase 4
• A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal AnemiaCompletedNCT02569515Phase 4
• A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic MalignanciesCompletedNCT02564094Phase 4
• A Study of Epoetin Beta (NeoRecormon) in Participants With Solid TumorsCompletedNCT02554942Phase 4
• Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in PakistanCompletedNCT02444845
• An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS)CompletedNCT02042833
• An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)CompletedNCT01974271
• A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on DialysisNo longer availableNCT01892202
• A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)CompletedNCT01756612
• An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical PracticeCompletedNCT01690455
• An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)CompletedNCT01667380
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or DialysisCompletedNCT01309295
• An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)CompletedNCT01213485
• A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic NephropathyCompletedNCT01191983Phase 4
• An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal AnemiaCompletedNCT01105494
• A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease PatientsCompletedNCT00922610Phase 4
• A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid MalignanciesCompletedNCT00776425Phase 4
• A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.CompletedNCT00773331Phase 3
• A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.CompletedNCT00717821Phase 3
• A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.TerminatedNCT00680563Phase 3
• A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on DialysisCompletedNCT00642967Phase 3
• Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) PatientsCompletedNCT00628043Phase 3
• A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney TransplantTerminatedNCT00576602Phase 4
• A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.WithdrawnNCT00560547Phase 3
• A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.CompletedNCT00560274Phase 4
• A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.CompletedNCT00442793Phase 3
• A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.TerminatedNCT00440063Phase 4
• A Study of NeoRecormon in Patients With Chronic Kidney Disease.CompletedNCT00437723Phase 4
• Clinical Study of R744 to Predialysis PatientsCompletedNCT00433615Phase 3
• A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.CompletedNCT00413101Phase 4
• COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.CompletedNCT00377481Phase 4
• A Study of Mircera in Anemic Patients With Multiple MyelomaCompletedNCT00360347Phase 1/2